Intervention: Investigator's Choice of Intravesical Chemotherapy
Found 5 matching trials
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
PHASE2
The purpose of this study is to evaluate recurrence-free survival (RFS) in ...
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
PHASE3
The goal of this clinical trial is to learn if TARA-002 can treat high-grad...
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
PHASE3
The purpose of study is to compare bladder intact-event free survival (BI-E...